Cargando…

Efficacy and Safety of Armolipid Plus(®): An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

Armolipid Plus(®) is a multi-constituent nutraceutical that claims to improve lipid profiles. The aim of this PRISMA compliant systematic review and meta-analysis was to globally evaluate the efficacy and safety of Armolipid Plus(®) on the basis of the available randomized, blinded, controlled clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cicero, Arrigo F. G., Kennedy, Cormac, Knežević, Tamara, Bove, Marilisa, Georges, Coralie M. G., Šatrauskienė, Agnė, Toth, Peter P., Fogacci, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920267/ https://www.ncbi.nlm.nih.gov/pubmed/33669333 http://dx.doi.org/10.3390/nu13020638

Ejemplares similares

Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies
por: Fogacci, Federica, et al.
Publicado: (2020)

Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus(®) and placebo
por: Cicero, Arrigo F.G., et al.
Publicado: (2023)

Effect of Dietary Supplementation with Eufortyn(®) Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study
por: Fogacci, Federica, et al.
Publicado: (2022)

Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection
por: Bove, Marilisa, et al.
Publicado: (2021)

Effect of combined lipid-lowering and antioxidant nutraceutical on plasma lipids, endothelial function, and estimated cardiovascular disease risk in moderately hypercholesterolemic patients: a double-blind, placebo-controlled randomized clinical trial
por: Cicero, Arrigo F.G., et al.
Publicado: (2021)

Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine
por: De Castro-Orós, Isabel, et al.
Publicado: (2016)

Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
por: Cicero, Arrigo F. G., et al.
Publicado: (2019)

Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2016)

Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
por: Cicero, Arrigo F. G., et al.
Publicado: (2017)

Prevalent Seasoning and Cooking Fats, Arterial Stiffness and Blood Lipid Pattern in a Rural Population Sample: Data from the Brisighella Heart Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2017)

Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence
por: Fogacci, Silvia, et al.
Publicado: (2020)

The year in nutrition medicine 2023
por: Cicero, Arrigo F.G., et al.
Publicado: (2023)

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

Misinterpreting data in lipidology in the era of COVID-19
por: Fogacci, Federica, et al.
Publicado: (2020)

Diets, Foods and Food Components’ Effect on Dyslipidemia
por: Fogacci, Federica, et al.
Publicado: (2021)

Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts
por: Cicero, Arrigo F. G., et al.
Publicado: (2022)

An Evolving Definition of a “Healthy Diet”
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
por: Bove, Marilisa, et al.
Publicado: (2017)

Cutaneous fistulization of the hydatid disease: A PRISMA-compliant systematic review
por: Bahce, Zeynep Sener, et al.
Publicado: (2016)

Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis
por: Feng, Limin, et al.
Publicado: (2019)

Pediatric plexiform fibromyxoma: A PRISMA-compliant systematic literature review
por: Fukazawa, Mitsuharu, et al.
Publicado: (2019)

Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant Study
por: Zdanowicz, Katarzyna, et al.
Publicado: (2022)

Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
por: Fogacci, Federica, et al.
Publicado: (2019)

Hypertension and Dyslipidemia Combined Therapeutic Approaches
por: Borghi, Claudio, et al.
Publicado: (2022)

Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia
por: Cicero, Arrigo F. G., et al.
Publicado: (2022)

Realistic simulations of the AGATA Demonstrator plus PRISMA spectrometer
por: Ince, E, et al.
Publicado: (2010)

Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis
por: Wang, Qinjing, et al.
Publicado: (2022)

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes
por: Roesel, Raffaello, et al.
Publicado: (2023)

Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review
por: Ferioli, Martina, et al.
Publicado: (2022)

Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review
por: Wang, Ping, et al.
Publicado: (2020)

Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
por: Yu, Lu, et al.
Publicado: (2020)

The adoption of electronic medical record by physicians: A PRISMA-compliant systematic review
por: Dutta, Bireswar, et al.
Publicado: (2020)

Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
por: Cicero, Arrigo F. G., et al.
Publicado: (2020)

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial
por: Fogacci, Federica, et al.
Publicado: (2022)

Transanal hemorrhoidal dearterialization versus stapled hemorrhoidectomy in the treatment of hemorrhoids: A PRISMA-compliant updated meta-analysis of randomized control trials
por: Song, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_15kj9pdmo26md3p0uhv27r7vc6